JP6325553B2 - エールリヒア抗体の検出のためのペプチド、デバイス、および方法 - Google Patents

エールリヒア抗体の検出のためのペプチド、デバイス、および方法 Download PDF

Info

Publication number
JP6325553B2
JP6325553B2 JP2015536934A JP2015536934A JP6325553B2 JP 6325553 B2 JP6325553 B2 JP 6325553B2 JP 2015536934 A JP2015536934 A JP 2015536934A JP 2015536934 A JP2015536934 A JP 2015536934A JP 6325553 B2 JP6325553 B2 JP 6325553B2
Authority
JP
Japan
Prior art keywords
amino acid
group
seq
acid selected
peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2015536934A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016500815A (ja
JP2016500815A5 (enExample
Inventor
ラジェッシュ ケイ． メーラ
ラジェッシュ ケイ． メーラ
ケニス ピー． アロン
ケニス ピー． アロン
デニス エム． ブレイル
デニス エム． ブレイル
ティモシー ピー． フォーサイス
ティモシー ピー． フォーサイス
ジェレミー ディー． ウォーカー
ジェレミー ディー． ウォーカー
クリスティーナ アール． ケシコ
クリスティーナ アール． ケシコ
Original Assignee
アバクシス， インコーポレイテッド
アバクシス， インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by アバクシス， インコーポレイテッド, アバクシス， インコーポレイテッド filed Critical アバクシス， インコーポレイテッド
Publication of JP2016500815A publication Critical patent/JP2016500815A/ja
Publication of JP2016500815A5 publication Critical patent/JP2016500815A5/ja
Application granted granted Critical
Publication of JP6325553B2 publication Critical patent/JP6325553B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306—Solid-phase reaction mechanisms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/29—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Richettsiales (O)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K17/00—Carrier-bound or immobilised peptides; Preparation thereof
    • C07K17/14—Peptides being immobilised on, or in, an inorganic carrier
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/29—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Richettsiales (o)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
JP2015536934A 2012-10-11 2013-10-11 エールリヒア抗体の検出のためのペプチド、デバイス、および方法 Active JP6325553B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261712578P 2012-10-11 2012-10-11
US61/712,578 2012-10-11
PCT/US2013/064536 WO2014059274A1 (en) 2012-10-11 2013-10-11 Peptides, devices, and methods for the detection of ehrlichia antibodies

Publications (3)

Publication Number Publication Date
JP2016500815A JP2016500815A (ja) 2016-01-14
JP2016500815A5 JP2016500815A5 (enExample) 2016-10-27
JP6325553B2 true JP6325553B2 (ja) 2018-05-16

Family

ID=50477922

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015536934A Active JP6325553B2 (ja) 2012-10-11 2013-10-11 エールリヒア抗体の検出のためのペプチド、デバイス、および方法

Country Status (10)

Country Link
US (5) US9651546B2 (enExample)
EP (1) EP2906950B1 (enExample)
JP (1) JP6325553B2 (enExample)
KR (1) KR102106762B1 (enExample)
CN (1) CN105051541B (enExample)
AU (1) AU2013329025B2 (enExample)
BR (1) BR112015008036B1 (enExample)
CA (1) CA2886989C (enExample)
ES (1) ES2668863T3 (enExample)
WO (1) WO2014059274A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2501718B1 (en) 2009-11-20 2016-07-27 Abaxis, Inc. Peptides, devices, and methods for the detection of ehrlichia antibodies
CN104105965B (zh) * 2011-11-21 2016-07-06 爱贝斯股份有限公司 侧向流和相关免疫测定中的信号放大
BR112015008036B1 (pt) 2012-10-11 2022-09-13 Zoetis Services Llc População de peptídeos isolados, método para detectar em uma amostra um anticorpo, método para diagnosticar erliquiose monocítica e/ou granulocítica, método para detectar a presença de anticorpos e kit
US9194870B2 (en) 2014-01-21 2015-11-24 Abaxis, Inc. Peptides, devices, and methods for the detection of Anaplasma antibodies
US9442112B2 (en) * 2014-04-04 2016-09-13 Abaxis, Inc. Compositions and methods for identifying Ehrlichia species
TWI691716B (zh) 2014-08-13 2020-04-21 美商艾巴希斯公司 電漿特異性結合搭配物檢定中之信號放大
PT3331818T (pt) 2015-08-04 2024-08-30 Zoetis Services Llc Amplificação de sinal em ensaios de parceiro de ligação específica plasmónicos à base de solução
EP3572810B1 (en) * 2017-01-20 2024-10-30 Shenzhen New Industries Biomedical Engineering Co., Ltd. Labelled complex and preparation method therefor, and kit, use and detection system thereof
KR102486615B1 (ko) 2017-01-30 2023-01-11 조에티스 서비시즈 엘엘씨 용액-기반 플라스몬 특이적-결합 파트너 검정 및 금속성 나노구조체
US12377139B2 (en) * 2017-07-12 2025-08-05 Kansas State University Research Foundation Ehrlichia ruminantium immunogenic compositions and methods of using thereof
ES2953017T3 (es) 2018-04-03 2023-11-07 Sanofi Sa Dispositivo de tira de inmunoensayo de flujo lateral
WO2020067233A1 (ja) * 2018-09-27 2020-04-02 積水メディカル株式会社 イムノクロマト用試験片
US20240272168A1 (en) * 2023-02-14 2024-08-15 Advanced Biosystems, Inc. Immunostaining using protein conjugates

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4366246A (en) 1977-11-08 1982-12-28 Genentech, Inc. Method for microbial polypeptide expression
US4617262A (en) * 1983-07-22 1986-10-14 Cooperbiomedical, Inc. Assaying for circulating immune complexes with labeled protein A
US6284238B1 (en) 1995-06-06 2001-09-04 Aquila Biopharmaceuticals, Inc. Cell lines infected with granulocytic ehrlichia, vaccines, diagnostics and methods
US6451315B1 (en) 1996-10-01 2002-09-17 Corixa Corporation Compounds and methods for the diagnosis and treatment of B. microti infection
US6653128B2 (en) 1996-10-17 2003-11-25 University Of Florida Nucleic acid vaccines against rickettsial diseases and methods of use
US6593147B1 (en) * 1996-10-17 2003-07-15 University Of Florida Research Foundation, Inc. Nucleic acid vaccines against rickettsial diseases and methods of use
US6231869B1 (en) 1997-03-21 2001-05-15 Corixa Corporation Compounds and methods for the diagnosis and treatment of ehrlichia infection
US6207169B1 (en) * 1997-03-21 2001-03-27 Corixa Corporation Compounds and methods for the diagnosis and treatment of Ehrlichia infection
US6204252B1 (en) 1997-04-25 2001-03-20 Aquila Biopharmaceuticals, Inc. Characterization of granulocytic ehrlichia and methods of use
DE69841899D1 (de) 1997-09-19 2010-10-28 Ohio State Res Found Proteine der äusseren membran von ehrlichia chaffeensis
JP2002527042A (ja) * 1998-07-28 2002-08-27 アクウィラ・バイオファーマシューティカルズ・インコーポレイテッド 顆粒球エールリキア菌遺伝子およびその使用
US6043085A (en) 1998-08-27 2000-03-28 Research Development Foundation Ehrlichia canis 120-kDa immunodominant antigenic protein and gene
US6544517B1 (en) 1998-09-18 2003-04-08 The Ohio State University Research Foundation Outer membrane protein of Ehrlichia canis and Ehrlichia chaffeensis
US7888491B2 (en) 1998-09-18 2011-02-15 The Ohio State University Research Foundation Outer membrane protein of Ehrlichia canis and Ehrlichia chaffeensis
US6893640B2 (en) 1998-09-18 2005-05-17 The Ohio State University Research Foundation Outer membrane protein of Ehrlichia canis and Ehrlichia chaffeensis
RU2237716C2 (ru) 1998-11-30 2004-10-10 Рисерч Дивелопмент Фаундейшн Последовательность днк, кодирующая белок ehrlichia canis с молекулярной массой 30 килодальтон, вектор, рекомбинантный белок и способ его получения
US6392023B1 (en) 1999-03-03 2002-05-21 Research Development Foundation Homologous 28-kilodalton immunodominant protein genes of Ehrlicha canis and uses thereof
CA2375650A1 (en) 1999-07-21 2001-02-01 Yung-Fu Chang Ehrlichia canis genes and vaccines
US6355777B1 (en) 2000-04-28 2002-03-12 Research Development Foundation P43 antigen for the immunodiagnosis of canine ehrlichiosis and uses thereof
US7407770B2 (en) 2001-01-18 2008-08-05 Idexx Corporation Compositions and methods for detection of Ehrlichia canis and Ehrlichia chaffeensis antibodies
US7183060B2 (en) 2005-02-22 2007-02-27 Idexx Laboratories, Inc. Peptides for detection of antibody to Ehrlichia ewingii
US7087372B2 (en) 2001-01-18 2006-08-08 Idexx Laboratories, Inc. Compositions and methods for detection of Ehrlichia canis and Ehrlichia chaffeensis antibodies
US20030194756A1 (en) 2002-04-12 2003-10-16 O'connor Thomas Patrick Peptides for detection of antibody to Ehrlichia equi
DK1384075T3 (da) 2001-03-28 2010-04-26 Heska Corp Fremgangsmåder til detektering af tidlig renal sygdom hos dyr
US20030129161A1 (en) 2001-09-17 2003-07-10 Hsien-Jue Chu Interleukin-12 as a veterinary vaccine adjuvant
US7204992B2 (en) 2002-11-04 2007-04-17 Clayton Foundation For Research P153 and P156 antigens for the immunodiagnosis of canine and human ehrlichioses and uses thereof
WO2004084841A2 (en) 2003-03-27 2004-10-07 Heska Corporation Novel anti-feline albumin antibodies and methods of detecting early renal disease
US7304139B2 (en) 2003-10-28 2007-12-04 University Of Florida Research Foundation, Inc. Polynucleotides and polypeptides of Anaplasma phagocytophilum and methods of using the same
US20050202046A1 (en) 2004-03-11 2005-09-15 Wyeth Canine vaccine for protection against ehrlichiosis
US20060046310A1 (en) 2004-08-25 2006-03-02 Zong-Li Xia Amplification method for solid phase immunoassays
AU2006231473B2 (en) 2005-04-04 2012-01-12 Idexx Laboratories, Inc. Ehrlichia canis DIVA (differentiate infected from vaccinated animals)
US7842474B2 (en) 2005-04-04 2010-11-30 Idexx Laboratories, Inc. Ehrlichia canis DIVA (differentiate infected from vaccinated animals)
MX2007016189A (es) 2005-06-16 2008-03-10 Res Dev Foundation Ortologos de proteinas inmunoreactivas de ehrlichia canis y e. chaffeensis.
US20090176208A1 (en) 2006-01-04 2009-07-09 Simon Brodie Methods for detecting, identifying and reporting the presence of animal pathological agents
US7776618B2 (en) 2007-03-01 2010-08-17 Church & Dwight Co., Inc. Diagnostic detection device
US7507789B2 (en) 2007-04-09 2009-03-24 Idexx Laboratories, Inc. Detection of Anaplasma platys
US8784828B2 (en) * 2007-05-04 2014-07-22 The Ohio State University Research Foundation Ehrlichia ewingii proteins, nucleic acids, and methods of their use
US7964366B2 (en) 2007-09-21 2011-06-21 Idexx Laboratories, Inc. Methods and compositions for detection of Ehrlichia chaffeensis (VLPT)
BRPI0816437B8 (pt) 2007-09-21 2021-05-25 Idexx Lab Inc polipeptídeos purificados e métodos para a detecção de ehrlichia chaffeensis em uma amostra teste
ES2720363T3 (es) 2007-10-31 2019-07-19 Idexx Lab Inc Ehrlichia canis DIVA (de diferenciación entre animales infectados y vacunados)
EP2501718B1 (en) * 2009-11-20 2016-07-27 Abaxis, Inc. Peptides, devices, and methods for the detection of ehrlichia antibodies
BR112015008036B1 (pt) 2012-10-11 2022-09-13 Zoetis Services Llc População de peptídeos isolados, método para detectar em uma amostra um anticorpo, método para diagnosticar erliquiose monocítica e/ou granulocítica, método para detectar a presença de anticorpos e kit
CN103060468B (zh) 2013-01-30 2014-02-12 扬州大学 一种埃里希氏菌的荧光定量pcr检测和分型的引物、探针及试剂盒
US9442112B2 (en) 2014-04-04 2016-09-13 Abaxis, Inc. Compositions and methods for identifying Ehrlichia species

Also Published As

Publication number Publication date
US20140121125A1 (en) 2014-05-01
ES2668863T3 (es) 2018-05-22
US9651546B2 (en) 2017-05-16
US10948487B2 (en) 2021-03-16
AU2013329025A1 (en) 2015-04-23
US20140212898A1 (en) 2014-07-31
BR112015008036A2 (pt) 2017-11-28
EP2906950A1 (en) 2015-08-19
JP2016500815A (ja) 2016-01-14
CN105051541B (zh) 2017-07-04
KR102106762B1 (ko) 2020-05-06
CN105051541A (zh) 2015-11-11
CA2886989A1 (en) 2014-04-17
CA2886989C (en) 2022-05-17
KR20150065744A (ko) 2015-06-15
US9157913B2 (en) 2015-10-13
EP2906950B1 (en) 2018-03-21
US20160054313A1 (en) 2016-02-25
WO2014059274A1 (en) 2014-04-17
AU2013329025B2 (en) 2019-07-04
US20180106792A1 (en) 2018-04-19
US9696300B2 (en) 2017-07-04
US20190391139A1 (en) 2019-12-26
US10444231B2 (en) 2019-10-15
EP2906950A4 (en) 2016-05-25
BR112015008036B1 (pt) 2022-09-13

Similar Documents

Publication Publication Date Title
JP6325553B2 (ja) エールリヒア抗体の検出のためのペプチド、デバイス、および方法
KR102503883B1 (ko) 라임 질환 항체의 검출을 위한 펩타이드 및 방법
CN102834411B (zh) 用于检测埃里希体属抗体的肽、装置和方法
JP6738274B2 (ja) アナプラズマ抗体を検出するためのペプチド、器具、および方法
JP2013511530A (ja) ライム病抗体の検出のためのペプチドおよび方法

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20160905

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20160905

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20170615

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20170802

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20171020

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20180329

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20180412

R150 Certificate of patent or registration of utility model

Ref document number: 6325553

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313113

S533 Written request for registration of change of name

Free format text: JAPANESE INTERMEDIATE CODE: R313533

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250